Glenmark Pharma reports 7% rise in Q2 consolidated net profit

31 Oct 2014 Evaluate

Glenmark Pharmaceuticals has reported results for second quarter ended September 30, 2014.

The company has registered 9.89% rise in its net profit at Rs 116.43 crore for the quarter under review as compared to Rs 105.95 crore for the same quarter in the previous year. Total income of the company has increased 17.44% at Rs 711.75 crore for Q2FY15 as compared Rs 606.03 crore for the corresponding quarter previous year.

On consolidated basis, the company’s net profit after taxes and minority interest and share of profit of associates for the quarter under review registered 6.99% growth at Rs 165.08 crore against Rs 154.30 crore in the September quarter of previous fiscal. The company’s total income has increased by 13.87% at Rs 1681.68 crore for the quarter from Rs 1476.78 crore in the similar quarter of previous year.

Glenmark Pharma Share Price

1992.70 -8.35 (-0.42%)
28-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1610.15
Dr. Reddys Lab 1224.30
Cipla 1328.25
Zydus Lifesciences 896.60
Lupin 2121.65
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×